Hall MJ - Search Results

1

BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer.

Hall MJ, Reid JE, Burbidge LA, Pruss D, Deffenbaugh AM, Frye C, Wenstrup RJ, Ward BE, Scholl TA, Noll WW. Hall MJ, et al. Cancer. 2009 May 15;115(10):2222-33. doi: 10.1002/cncr.24200. Cancer. 2009. PMID: 19241424 Free PMC article.

2

Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer.

Hershman D, Hall MJ, Wang X, Jacobson JS, McBride R, Grann VR, Neugut AI. Hershman D, et al. Among authors: hall mj. Cancer. 2006 Dec 1;107(11):2581-8. doi: 10.1002/cncr.22316. Cancer. 2006. PMID: 17078055 Free article.

3

Cost effectiveness of pharmacogenetic testing for uridine diphosphate glucuronosyltransferase 1A1 before irinotecan administration for metastatic colorectal cancer.

Gold HT, Hall MJ, Blinder V, Schackman BR. Gold HT, et al. Among authors: hall mj. Cancer. 2009 Sep 1;115(17):3858-67. doi: 10.1002/cncr.24428. Cancer. 2009. PMID: 19517472 Free PMC article.

4

Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer.

Forman AD, Hall MJ. Forman AD, et al. Among authors: hall mj. Breast J. 2009 Sep-Oct;15 Suppl 1:S56-62. doi: 10.1111/j.1524-4741.2009.00798.x. Breast J. 2009. PMID: 19775331 Review.

5

Prevalence of BRCA1 and BRCA2 mutations in women with breast carcinoma In Situ and referred for genetic testing.

Hall MJ, Reid JE, Wenstrup RJ. Hall MJ, et al. Cancer Prev Res (Phila). 2010 Dec;3(12):1579-85. doi: 10.1158/1940-6207.CAPR-09-0218. Cancer Prev Res (Phila). 2010. PMID: 21149333 Free PMC article.

6

Rates and predictors of colorectal cancer screening by race among motivated men participating in a Prostate Cancer Risk Assessment Program.

Hall MJ, Ruth K, Giri VN. Hall MJ, et al. Cancer. 2012 Jan 15;118(2):478-84. doi: 10.1002/cncr.26315. Epub 2011 Jul 12. Cancer. 2012. PMID: 21751189 Free PMC article.

7

Genetic testing for hereditary cancer predisposition: BRCA1/2, Lynch syndrome, and beyond.

Hall MJ, Obeid EI, Schwartz SC, Mantia-Smaldone G, Forman AD, Daly MB. Hall MJ, et al. Gynecol Oncol. 2016 Mar;140(3):565-74. doi: 10.1016/j.ygyno.2016.01.019. Epub 2016 Jan 23. Gynecol Oncol. 2016. PMID: 26812021 Free PMC article. Review.

8

Oncologists' perceptions of tumor genomic profiling and barriers to communicating secondary hereditary risks to African American cancer patients.

Hall MJ, D'Avanzo PA, Chertock Y, Kelly PJA, Brajuha J, Singley K, Luck CC, Bass SB. Hall MJ, et al. BMC Cancer. 2024 Apr 2;24(1):412. doi: 10.1186/s12885-024-12184-y. BMC Cancer. 2024. PMID: 38566032 Free PMC article.

9

Review: only women with specific family histories should be referred for counseling or evaluation for BRCA breast and ovarian cancer susceptibility testing.

Hall MJ, Neugut AI. Hall MJ, et al. ACP J Club. 2006 Mar-Apr;144(2):37. ACP J Club. 2006. PMID: 16539352 No abstract available.

10

Disparities in genetic testing: thinking outside the BRCA box.

Hall MJ, Olopade OI. Hall MJ, et al. J Clin Oncol. 2006 May 10;24(14):2197-203. doi: 10.1200/JCO.2006.05.5889. J Clin Oncol. 2006. PMID: 16682739 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

516 results

Search Page

Filters